April 16, 2026 — Abbott Laboratories trimmed its full-year adjusted profit forecast after completing its acquisition of cancer-test maker Exact Sciences, saying the deal will reduce 2026 earnings by about $0.20 a share. Abbott now expects adjusted EPS of $5.38 to $5.58, down from a prior range of $5.55 to $5.80. The company reported first-quarter revenue of roughly $11.2 billion and adjusted EPS of $1.15, narrowly beating estimates. Diagnostics revenue was about $2.18 billion and medical devices revenue roughly $5.54 billion, while the nutrition business showed continued weakness. Management said the Exact Sciences purchase — valued at roughly $21–23 billion in reported coverage — could add about $3 billion in incremental sales in 2026 but has brought near-term financing and dilution pressures. The guidance revision and acquisition timing prompted an intraday share decline of around 4–6% and sparked investor concern. Abbott also noted limited logistics disruption from the Middle East conflict and said it has boosted local inventories to mitigate supply risks.

Netflix co-founder and chairman Reed Hastings will not stand for re-election when his board term expires in June, the company said on April 16, 2026, marking the formal end of a near-30-year association that transformed Netflix from a DVD-by-mail start-up to a global streaming giant. The announcement accompanied first-quarter results showing revenue of $12.25 billion (up about 16% year-on-year) and net income of $5.28 billion, boosted in part by a $2.8 billion termination fee after Netflix withdrew from a bid for Warner Bros. Discovery. Management warned that second-quarter earnings would fall short of analyst forecasts, sending shares down roughly 8–9% in after-hours trading. Netflix reiterated its strategic priorities — more programming, technology-led experiences including generative AI and a planned mobile revamp, and monetisation via an expanding ad business it expects to deliver about $3 billion in 2026 — while exploring live sports, video podcasts and games as growth levers. Hastings said he will focus on philanthropy and other pursuits after leaving the board.

PepsiCo on April 16 reported first-quarter results that topped Street expectations as its North America food business returned to volume growth. Adjusted EPS was $1.61 versus $1.55 expected and revenue rose to $19.44 billion, up 8.5% year‑on‑year. Net income attributable to the company was about $2.33 billion ($1.70 per share). Organic revenue increased 2.6%, supported by the acquisition of Poppi and new product distribution, while North America Foods volume grew roughly 2% after targeted price cuts of up to about 15% on brands including Lay’s, Doritos and Tostitos. North America beverages saw volume decline about 2.5%. Management reiterated full‑year guidance for organic revenue growth of 2–4% and core EPS growth of 4–6%, flagged ongoing inflation and geopolitical uncertainty related to the Middle East, and said systematic commodity hedges and productivity programs should provide near‑term visibility. The company also signalled a Gatorade brand restage and continued investment in growth platforms; shares and options activity rose on the news and institutional buying was highlighted in filings.

Between April 16-17, 2026 Tesla signalled a major step toward vertically integrating electric vehicles, humanoid robots and semiconductors. Allan (Wang) Hao, Tesla China president, called the Shanghai Gigafactory a “golden key” for mass-producing the Gen 3 Optimus robot, citing the plant’s 2025 output (about 851,000 EVs) and local supplier density. Tesla has deployed more than 1,000 Gen 3 units internally and is targeting production-scale manufacturing from 2026–2028, with aspirational internal targets for large annual volumes. Parallel to that, CEO Elon Musk’s Terafab initiative is advancing: Tesla is recruiting semiconductor engineers (including outreach to Taiwan), engaging suppliers such as Applied Materials, Tokyo Electron and Lam Research, and reported an AI5 chip tape-out that executives say boosts compute for AI and robotics. Market-focused reports note a strong stock response to chip progress but flag high valuation metrics and insider sales (~$20.9m). Separately, Cybertruck registration data show a drop in retail demand partly offset by purchases from Musk-owned companies. No formal timelines or capital commitments for large-scale robot or wafer production have been disclosed.

Global equity markets rallied on April 15-16, 2026, as hopes for a de-escalation in the U.S.-Iran conflict and a Reuters-reported 10-day Israel-Lebanon ceasefire propelled the S&P 500 and Nasdaq Composite to fresh closing and intraday records. The S&P closed above 7,000 and the Nasdaq notched multi-session winning streaks (11-12 days), while small-cap Russell 2000 also reached record highs. The move was supported by resilient corporate earnings — banks including Morgan Stanley and Bank of America, and PepsiCo surprised on the upside — and stronger-than-expected U.S. jobs data. At the same time oil prices rose (Brent near $99.39, U.S. crude around $94.69) as flows through the Strait of Hormuz remained constrained and global supply buffers tightened. Safe-haven assets and Treasuries eased as risk appetite returned; the dollar retraced some declines. Strategists cautioned that markets were still highly sensitive to news from the Middle East and that further concrete progress on negotiations would be needed to sustain the rally.